Q2 2022 Holdings
Filed 2022-08-15 | 107 holdings | $861.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $245.5M | 1,683,362 | 28.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $167.7M | 442,635 | 19.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $100.6M | 2,561,182 | 11.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $83.2M | 3,084,215 | 9.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $62.0M | 1,618,819 | 7.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $59.5M | 4,224,109 | 6.9% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $23.3M | 3,094,825 | 2.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $21.4M | 1,276,276 | 2.5% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $20.1M | 913,789 | 2.3% |
| Apyx Medical Corporation(APYX) | COM | 03837C106 | $19.9M | 3,398,279 | 2.3% |
| Cryoport Inc(CYRX) | COM PAR $0.001 | 229050307 | $10.4M | 335,299 | 1.2% |
| Align Technology Inc(ALGN) | COM | 016255101 | $9.9M | 42,000 | 1.2% |
| Cytek Biosciences Inc(CTKB) | COM | 23285D109 | $9.8M | 916,838 | 1.1% |
| Codexis Inc(CDXS) | COM | 192005106 | $9.6M | 920,448 | 1.1% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $9.4M | 764,701 | 1.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $5.2M | 2,849,707 | 0.6% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $507.0K | 106,667 | 0.1% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $236.6K | 435,500 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $217.4K | 15,802,802 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $202.1K | 5,045,307 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $176.5K | 1,350,993 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $149.1K | 3,996,154 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $128.8K | 2,369,138 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $126.4K | 1,882,663 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $104.0K | 564,375 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $90.0K | 3,189,605 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $88.7K | 3,522,904 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $87.0K | 698,371 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $81.9K | 1,373,284 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $75.2K | 2,122,283 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $69.7K | 4,795,000 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $66.9K | 1,179,965 | 0.0% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $66.4K | 1,770,400 | 0.0% |
| Globus MED Inc(GMED) | CL A | 379577208 | $63.0K | 1,121,527 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $62.6K | 4,395,677 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $57.7K | 3,951,281 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $54.6K | 922,630 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $50.1K | 2,637,581 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $48.2K | 3,651,823 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $45.6K | 1,845,366 | 0.0% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $43.4K | 959,481 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $37.9K | 4,794,499 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $37.3K | 924,887 | 0.0% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $29.5K | 1,819,120 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $29.4K | 2,013,601 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $26.5K | 4,315,102 | 0.0% |
| Cincor Pharma Inc | COM | 17240Y109 | $26.2K | 1,389,705 | 0.0% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $25.1K | 2,220,983 | 0.0% |
| Olink Hldg AB | SPONSORED ADS | 680710100 | $23.7K | 1,562,222 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $21.6K | 2,168,957 | 0.0% |